Applied Therapeutics Inc (APLT)
0.8533
-0.03
(-3.76%)
USD |
NASDAQ |
Dec 27, 16:00
0.86
+0.01
(+0.79%)
After-Hours: 20:00
Applied Therapeutics Research and Development Expense (Quarterly): 14.83M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | 219.76M |
Cassava Sciences Inc | 17.68M |
Verastem Inc | 24.75M |
Cellectar Biosciences Inc | 5.494M |
Aptevo Therapeutics Inc | 3.103M |